METHOD OF TREATING INTERSTITIAL CYSTITIS WITH RECOMBINANT HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR (HB-EGF) - Patent 1075271

(19)

(11)

EP 1 075 271 A2

(12)

(88)	Date of publication A3:
	06.04.2000

(43)	Date of publication:
	14.02.2001 Bulletin 2001/07

(21)	Application number: 99917600.1

(22)	Date of filing: 16.04.1999

(51)	International Patent Classification (IPC)⁷: A61K 38/16, A61K 38/18, A61K 48/00

(86)	International application number:
	PCT/US9908/441

(87)	International publication number:
	WO 9954/706 (28.10.1999 Gazette 1999/43)

(84)	Designated Contracting States:
	DE DK FR GB IE IT NL

(30)

Priority:

17.04.1998 US 82070 P

(71)	Applicants:
	Keay, Susan Ellicot City, MD 21042 (US) Warren, John Baltimore, MD 21209 (US) Hise, Michael Columbia, MD 21045 (US)

(72)	Inventors:
	KEAY, Susan Ellicott City, MD 21042 (US) WARREN, John Baltimore, MD 21209 (US) HISE, Michael Columbia, MD 21045 (US)

(74)	Representative: Marchant, James Ian et al
	Elkington and Fife,Prospect House,8 Pembroke Road Sevenoaks,Kent TN13 1XR Sevenoaks,Kent TN13 1XR (GB)

(54)	METHOD OF TREATING INTERSTITIAL CYSTITIS WITH RECOMBINANT HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR (HB-EGF)